Clik here to view.
scPharmaceuticals’ drug/device combo aims at replacing IVs in antibiotic drug...
scPharmaceuticals has raised $3.6 million in what looks to be a bridge financing round for its drug/device combo that could replace IV use in treating heart failure and infections.
View ArticleClik here to view.
Maker of neuromodulator to treat heart failure, CVRx, raises $46M
Neuromodulation is gaining ground as a therapy for reducing pain, but no one has yet harnessed it within the cardiology arena, putting the company in a unique position if the Barostim gains FDA...
View ArticleClik here to view.
Robotic sleeve shows promise against heart failure
The device could be the next evolution in assistive technology, helping manage congestive heart failure more safely.
View ArticleClik here to view.
Mass General launches study on Jana Care’s heart failure management app
Massachusetts General Hospital is working with Jana Care to conduct a study on the company’s heart failure management mobile app, called Heart Habits.
View ArticleClik here to view.
Study highlights how EHR data can pinpoint undiagnosed genetic diseases
The study out of Vanderbilt University Medical Center found 14 percent of individuals with genetic variants impacting the kidney had kidney transplants and 10 percent with another variant had liver...
View ArticleClik here to view.
How much do EHRs impact heart failure patient care?
A new study in the Journal of the American Heart Association found there was not an association between a hospital’s degree of EHR implementation and improved quality of care and outcomes for heart...
View ArticleClik here to view.
San Francisco startup raises $6.75 million for remote health monitoring
The company was founded last year and has developed technology that analyzes data from a combination of clinical and commercial devices to monitor and track the health status of patients at home.
View ArticleClik here to view.
Irish med device startup raises $30M, brings in new CEO, to better treat...
WhiteSwell is pitching a technology to better treat acute decompensated heart failure by finding an alternative route to decongest the fluid back-up caused by the heart’s inability to pump effectively.
View ArticleClik here to view.
Pitch Perfect Winner Spotlight: CorInnova wants to change the way we treat...
Houston-based CorInnova won the medical device track for the Pitch Perfect contest at the MedCity INVEST conference in Chicago.
View ArticleClik here to view.
Massachusetts-based Biofourmis to acquire Zurich wearable company
Biofourmis’s CEO boldly declared the company will become a unicorn and this acquisition is expected to give the startup access to more raw data as it expands its analytics platforms and brings...
View ArticleClik here to view.
Study shows mental health services key for handling heart failure
Heart failure patients reported reduced depression symptoms and better self-care after receiving behavioral therapy through telehealth services, according to a small study by AbleTo and Humana.
View ArticleClik here to view.
AstraZeneca lands first big partner for digital health platform
The drugmaker struck a collaboration agreement with Mass General to use its platform for heart failure and asthma management. The health system plans to launch two pilots of the digital health platform.
View ArticleClik here to view.
Software to calculate the right dose of medicine for heart failure patients...
Biofourmis, a Boston-based digital health startup, recently received breakthrough designation for its digital therapeutic to help ensure heart failure patients receive medications that are consistent...
View ArticleClik here to view.
Cadence launches with $41M, strikes partnership with LifePoint Health
The company offers a remote patient monitoring platform that enables clinicians to not only monitor patients at home but also provide personalized feedback via texts and video visits. The platform will...
View ArticleClik here to view.
Abbott seeks expanded indication, national coverage for CardioMEMS device
With the results of a recent trial, Abbott is seeking an expanded indication from the FDA for its CardioMEMS device, intended to prevent hospitalizations in patients with heart failure. It’s also...
View ArticleClik here to view.
Study: Rural hospitals that merged or were bought saw death rates drop
The mortality rates at rural hospitals for certain conditions, including heart attacks and stroke, decreased in the years following a merger or an acquisition compared with facilities that remained...
View ArticleClik here to view.
To reduce heart attack rates, make CCTA the new standard of care
To improve heart attack prevention, there is an urgent unmet need to modernize our approach from late-stage symptom-driven care to direct disease-based care, a care paradigm that addresses heart attack...
View ArticleClik here to view.
WellSky’s in-home care pilot with Ohio academic medical center aims to reduce...
WellSky will pilot its ReD technology at The OSU Wexner Medical Center with the goal to help heart failure patients avoid hospital readmissions. The technology allows providers to assess the fluid...
View ArticleClik here to view.
Imara’s two trial flops in blood disorders dim drug’s prospects in heart failure
The lead drug candidate of Imara failed two separate mid-stage clinical trials evaluating it in rare, inherited hemoglobin disorders. Imara had been planning to advance the small molecule to yet...
View ArticleClik here to view.
CEO of cardiology startup declares that its tech could potentially cure heart...
Ceryx’s device, Cysoni, is designed to pace the heart in rhythm with a person’s respiration, so that the heart rate and breathing are synced. This is typically the case for a healthy person, but for...
View ArticleClik here to view.
Could AI and an Apple Watch ECG improve the prognosis for heart failure?
Early detection and treatment of heart failure can greatly improve an otherwise poor prognosis. Research from Mayo Clinic suggests artificial intelligence could be used to detect the condition even...
View ArticleClik here to view.
Rocket Pharma stocks up on cardiac gene therapies with $53M Renovacor...
Rocket Pharmaceuticals is acquiring Renovacor, a gene therapies developer whose lead program addresses a particular genetic mutation that leads to a type of heart failure. The all-stock deal gives...
View ArticleClik here to view.
Intermountain Partners with Story Health to Better Manage Heart Failure...
Intermountain Healthcare recently partnered with Story Health to help manage patients’ heart failure by increasing access to specialty care. Under the partnership, Intermountain clinicians are working...
View ArticleClik here to view.
After FDA Miss in Diabetes, Lexicon Lands Long-Awaited Approval in Heart Failure
Lexicon Pharmaceuticals drug Inpefa is now FDA-approved for heart failure. Inpefa is third in its class, but the biotech says its pill can reach a specific subset of patients, enabling it to stand...
View ArticleClik here to view.
Geisinger Launches Heart Failure Monitoring Program Using Bodyport’s Smart Scale
Geisinger is launching a pilot program in partnership with virtual heart failure monitoring startup Bodyport. About 200 of the health system’s heart failure patients will be using Bodyport’s cardiac...
View ArticleClik here to view.
Novo Nordisk Expands Cardio Reach by Buying Heart Drugs Biotech Cardior
Novo Nordisk’s strategy to grow beyond metabolic diseases includes expanding into adjacent areas such as cardiovascular disease. Acquiring Cardior Pharmaceuticals adds a novel RNA-based therapy that is...
View ArticleClik here to view.
Eko Health Gains FDA Clearance For Cardiology Algorithm That Can Detect Heart...
This week, Eko Health received FDA clearance for a new AI-powered tool that aids in the early detection of low ejection fraction, a key indicator of heart failure. The tool, which was developed in...
View ArticleClik here to view.
Bayer Looks to Expand Kerendia’s Label to Heart Failure After Phase 3 Win
Bayer reported a Phase 3 test of Kerendia in heart failure led to statistically significant reductions in cardiovascular death and hospitalizations. Detailed results will be presented during the...
View ArticleClik here to view.
FDA Clears Withings’ New Blood Pressure Monitor That Allows Providers to...
This week, the FDA granted clearance to Withings’ BPM Pro 2 cellular blood pressure monitor. The device seeks to help providers scale remote patient monitoring for heart failure patients. The post FDA...
View ArticleClik here to view.
Irish Startup Snags $120M for Heart Failure Implant
FIRE1 raised $120 million for its Norm system — a heart failure monitor implant that seeks to keep patients out of the hospital. The post Irish Startup Snags $120M for Heart Failure Implant appeared...
View Article